Pioneering vaccine strategy promises to outmaneuver antimicrobial resistance
Study introduces Reverse Vaccine Development as a strategic approach to identify correlates of protection early in vaccine development against antimicrobial-resistant pathogens, aiming to mitigate risks such as significant phase-III clinical trial failures.
Kateryna Kon Vaccine Development Npj Vaccines Reverse Vaccine Development Antimicrobial Resistance Clinical Trial
Source: news-medical.net